AstraZeneca PLC confirmed that its prescription blood-thinning medication Brilinta did not show any benefits over standard treatments for peripheral artery disease in...
In a new study recently conducted by the British multinational pharmaceutical and biologics company AstraZeneca on their new anti-clotting drug known as...